Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
Loui
L
Abdelghani
Kunjam
K
Modha
Eman
E
Albaddawi
Seshan
S
Subramanian
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000556:secondary; D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009318:Natriuresis / Q000187:drug effects; D012964:Sodium / Q000378:metabolism*
D000970:Antineoplastic Agents; D012964:Sodium; D002945:Cisplatin